During the past decade, Group Health Cooperative of Puget Sound Oncology Consortium conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Group Health Cooperative of Puget Sound Oncology Consortium" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "ID Biomedical Corporation, Quebec" with 1 trials sponsored, "SRI International" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Group Health Cooperative of Puget Sound Oncology Consortium" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Group Health Cooperative of Puget Sound Oncology Consortium" are "Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Diffuse Gastric Adenocarcinoma" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials), "Gastric Intestinal Type Adenocarcinoma" (1 trials) and "Gastric Mixed Adenocarcinoma" (1 trials). Many other conditions were trialed in "Group Health Cooperative of Puget Sound Oncology Consortium" in a lesser frequency.

Most popular intervention types in "Group Health Cooperative of Puget Sound Oncology Consortium" are "Drug" (7 trials), "Other" (5 trials), "Biological" (4 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Akt Inhibitor MK2206" (2 trials), "Bevacizumab" (2 trials), "Pharmacological Study" (2 trials) and "Bicalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Group Health Cooperative of Puget Sound Oncology Consortium" are 6 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Group Health Cooperative of Puget Sound Oncology Consortium". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Group Health Cooperative of Puget Sound Oncology Consortium, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Group Health Cooperative of Puget Sound Oncology Consortium, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".